Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 1
1971 1
1972 1
1973 1
1974 1
1975 1
1976 1
1978 1
1979 1
1980 2
1981 3
1982 2
1983 2
1984 3
1985 3
1986 4
1987 10
1988 9
1989 13
1990 22
1991 15
1992 15
1993 30
1994 32
1995 31
1996 36
1997 48
1998 42
1999 41
2000 48
2001 51
2002 51
2003 51
2004 49
2005 53
2006 45
2007 35
2008 51
2009 41
2010 57
2011 53
2012 63
2013 72
2014 66
2015 83
2016 126
2017 126
2018 94
2019 72
2020 114
2021 136
2022 89
2023 62

Text availability

Article attribute

Article type

Publication date

Search Results

1,905 results

Results by year

Filters applied: . Clear all
Page 1
Guillain-Barré syndrome.
Shahrizaila N, Lehmann HC, Kuwabara S. Shahrizaila N, et al. Lancet. 2021 Mar 27;397(10280):1214-1228. doi: 10.1016/S0140-6736(21)00517-1. Epub 2021 Feb 26. Lancet. 2021. PMID: 33647239 Review.
Guillain-Barre syndrome is the most common cause of acute flaccid paralysis worldwide. ...Results from the International Guillain-Barre Syndrome Outcome Study suggest that geographical variations exist in Guillain-Barre s
Guillain-Barre syndrome is the most common cause of acute flaccid paralysis worldwide. ...Results from the Internationa
Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment.
Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. Jasti AK, et al. Expert Rev Clin Immunol. 2016 Nov;12(11):1175-1189. doi: 10.1080/1744666X.2016.1193006. Epub 2016 Jun 21. Expert Rev Clin Immunol. 2016. PMID: 27292311 Free article. Review.
Guillain-Barre syndrome is a rare disease representing the most frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually reaching its peak within a month. ...Areas covered: In terms of etiology, Guillain-Barre s
Guillain-Barre syndrome is a rare disease representing the most frequent cause of acute flaccid symmetrical weakness of
Diagnosis and management of Guillain-Barré syndrome in ten steps.
Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Leonhard SE, et al. Nat Rev Neurol. 2019 Nov;15(11):671-683. doi: 10.1038/s41582-019-0250-9. Epub 2019 Sep 20. Nat Rev Neurol. 2019. PMID: 31541214 Free PMC article. Review.
Guillain-Barre syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. ...
Guillain-Barre syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and ne
Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.
van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. van den Berg B, et al. Nat Rev Neurol. 2014 Aug;10(8):469-82. doi: 10.1038/nrneurol.2014.121. Epub 2014 Jul 15. Nat Rev Neurol. 2014. PMID: 25023340 Review.
Guillain-Barre syndrome (GBS) is a potentially life-threatening postinfectious disease characterized by rapidly progressive, symmetrical weakness of the extremities. ...Molecular mimicry of pathogen-borne antigens, leading to generation of crossreactive antib
Guillain-Barre syndrome (GBS) is a potentially life-threatening postinfectious disease characterized by rapidly progres
Guillain-Barré syndrome.
Willison HJ, Jacobs BC, van Doorn PA. Willison HJ, et al. Lancet. 2016 Aug 13;388(10045):717-27. doi: 10.1016/S0140-6736(16)00339-1. Epub 2016 Mar 2. Lancet. 2016. PMID: 26948435 Review.
Under the umbrella term of Guillain-Barre syndrome are several recognisable variants with distinct clinical and pathological features. The severe, generalised manifestation of Guillain-Barre syndrome with respiratory failure affects 20-30 …
Under the umbrella term of Guillain-Barre syndrome are several recognisable variants with distinct clinical and patholo …
Guillain-Barre Syndrome.
Malek E, Salameh J. Malek E, et al. Semin Neurol. 2019 Oct;39(5):589-595. doi: 10.1055/s-0039-1693005. Epub 2019 Oct 22. Semin Neurol. 2019. PMID: 31639842 Review.
Guillain-Barre syndrome (GBS) is the leading cause of acute paralysis that can potentially affect all of the human population. ...
Guillain-Barre syndrome (GBS) is the leading cause of acute paralysis that can potentially affect all of the human popu
Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline.
Korinthenberg R, Trollmann R, Felderhoff-Müser U, Bernert G, Hackenberg A, Hufnagel M, Pohl M, Hahn G, Mentzel HJ, Sommer C, Lambeck J, Mecher F, Hessenauer M, Winterholler C, Kempf U, Jacobs BC, Rostasy K, Müller-Felber W. Korinthenberg R, et al. Eur J Paediatr Neurol. 2020 Mar;25:5-16. doi: 10.1016/j.ejpn.2020.01.003. Epub 2020 Jan 7. Eur J Paediatr Neurol. 2020. PMID: 31941581 Review.
This evidence- and consensus-based practical guideline for the diagnosis and treatment of Guillain-Barre Syndrome (GBS) in childhood and adolescence has been developed by a group of delegates from relevant specialist societies and organisations; it is the res …
This evidence- and consensus-based practical guideline for the diagnosis and treatment of Guillain-Barre Syndrome (GBS) …
Guillain-Barré syndrome and variants.
Dimachkie MM, Barohn RJ. Dimachkie MM, et al. Neurol Clin. 2013 May;31(2):491-510. doi: 10.1016/j.ncl.2013.01.005. Epub 2013 Feb 19. Neurol Clin. 2013. PMID: 23642721 Free PMC article. Review.
Guillain-Barre syndrome (GBS) is characterized by rapidly evolving ascending weakness, mild sensory loss, and hyporeflexia or areflexia. ...
Guillain-Barre syndrome (GBS) is characterized by rapidly evolving ascending weakness, mild sensory loss, and hyporefle
Guillain-Barré Syndrome.
Sheikh KA. Sheikh KA. Continuum (Minneap Minn). 2020 Oct;26(5):1184-1204. doi: 10.1212/CON.0000000000000929. Continuum (Minneap Minn). 2020. PMID: 33002998 Review.
PURPOSE OF REVIEW: This article reviews the clinical features, diagnosis and differential diagnosis, prognosis, pathogenesis, and current and upcoming treatments of Guillain-Barre syndrome (GBS). RECENT FINDINGS: GBS is an acute inflammatory neuropathic illne …
PURPOSE OF REVIEW: This article reviews the clinical features, diagnosis and differential diagnosis, prognosis, pathogenesis, and current an …
Immunotherapy of Guillain-Barré syndrome.
Liu S, Dong C, Ubogu EE. Liu S, et al. Hum Vaccin Immunother. 2018;14(11):2568-2579. doi: 10.1080/21645515.2018.1493415. Epub 2018 Jul 12. Hum Vaccin Immunother. 2018. PMID: 29953326 Free PMC article. Review.
Guillain-Barre syndrome (GBS), the most common cause of acute neuromuscular weakness and paralysis worldwide, encompasses a group of acute immune-mediated disorders restricted to peripheral nerves and roots. ...
Guillain-Barre syndrome (GBS), the most common cause of acute neuromuscular weakness and paralysis worldwide, encompass
1,905 results